Miromatrix Medical EBIT

Miromatrix Medical (MIRO) currently reports a EBIT of $-28M as of September 2023. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Miromatrix Medical's EBIT history and peer comparisons.

Miromatrix Medical's EBIT of $-28M is lower than the Healthcare sector average of $23B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Miromatrix Medical reported $-28M in EBIT as of September 2023. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-28M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Miromatrix Medical, and consider following MIRO for alerts when major investors trade the stock.

Miromatrix Medical is classified in the Healthcare sector. On EBIT, it currently shows $-28M versus a sector average near $23B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MIRO with unrelated industries.